In tumors, activation of the S100A8/A9/RAGE pathway has been shown to promote tumor progression in several types of cancer, including breast, prostate, and colorectal cancer, through the activation of the MAPK pathway and NF-kB [178,221,222]. This evidence concerns the gene IGKV1D-22 and neoplasm.